TSX Delisting Review - Aptose Biosciences Inc. (APS)
January 16, 2026
| Issuer: | Aptose Biosciences Inc. (the "Company") |
| Securities: |
Common Shares |
| Symbol(s): | APS |
| Delisting Review Type: | Remedial |
| Delisting Review Period: | TSX has decided to further extend its review of the eligibility of the Common Shares of the Company for continued listing for a period of 60 days. |
| Additional Information: | Please refer to TSX Bulletin 2025-0836 dated September 24, 2025. |
| TSX Contact: | Selma Thaver, Managing Director, TSX Listings |